| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/19/2006 | US7108987 Factors participating in degranulation of mast cells, DNAs encoding the same, method of screening of these factors and the inhibitors |
| 09/19/2006 | US7108975 Atlastin |
| 09/19/2006 | US7108854 Also an antibody which specifically binds to the protein and a Hybridoma cell line that produces the protein; immunoprophylactic uses |
| 09/19/2006 | US7108853 Surface protein of Leptospira |
| 09/19/2006 | US7108681 Microstructures for delivering a composition cutaneously to skin |
| 09/19/2006 | CA2308117C Novel nucleic acid sequence encoding flp recombinase |
| 09/19/2006 | CA2235269C Monoclonal antibody br110 and uses thereof |
| 09/19/2006 | CA2139877C Hematopoietic facilitatory cells and their uses |
| 09/19/2006 | CA2083493C Association between a human immunodeficiency virus-related retrovirus and sjogren's syndrome |
| 09/19/2006 | CA2074854C Imidazolinone resistant ahas mutants |
| 09/14/2006 | WO2006096459A2 Infectious, chimeric hepatitis c virus, methods of producing the same and methods of use thereof |
| 09/14/2006 | WO2006096451A2 Methionine sulfoxide antibodies |
| 09/14/2006 | WO2006096213A1 Polyamine sensors and methods of using the same |
| 09/14/2006 | WO2006095846A1 Model animal in which state of disease condition is observable in real time, gene construct for achieving the same and use of the same |
| 09/14/2006 | WO2006095769A1 Microorganism-derived psychrophilic endonuclease |
| 09/14/2006 | WO2006095731A1 CRYSTAL OF COMPLEX OF Rho-KINASE AND SUBSTANCE CAPABLE OF INTERACTING WITH Rho-KINASE |
| 09/14/2006 | WO2006095654A1 Reporter gene assay method |
| 09/14/2006 | WO2006095559A1 USE OF Fgf21 AS HEMATOPOIETIC FACTOR |
| 09/14/2006 | WO2006095439A1 Ultra-low temperature storage technique for cultured plant cells |
| 09/14/2006 | WO2006095431A1 Cell line culturable without aminal-derived component, method for establishment thereof, method for production of virus using the cell line and method for production of vaccine |
| 09/14/2006 | WO2006095424A1 Pump unit, syringe unit, particle feeding method, and cell feeding method |
| 09/14/2006 | WO2006095175A1 Directed neural differentiation |
| 09/14/2006 | WO2006095041A1 Method for the in vitro diagnosis of alzheimer's disease using a monoclonal antibody |
| 09/14/2006 | WO2006095034A1 Parthenocarpic tomatoes and production method thereof |
| 09/14/2006 | WO2006095011A1 Engineered human cells |
| 09/14/2006 | WO2006094828A2 Monoclonal antibodies and immunodetection assay specific for the chemotactic epitope of the urokinase-type plasminogen activator receptor |
| 09/14/2006 | WO2006094402A1 Novel hemoglobin scavenger receptor, cd163, and method of increasing cd163 expression on human stem cells and stimulation of erythroid progenitors |
| 09/14/2006 | WO2006094336A1 Generation of diploid reprogrammed cells through nuclear inactivation |
| 09/14/2006 | WO2006061242A3 Use of pta peptides for stratification of individuals having cancer |
| 09/14/2006 | WO2006060779A3 Novel methods, compositions and devices for inducing neovascularization |
| 09/14/2006 | WO2006031926A9 Methods for the isolation and expansion of cord blood derived t regulatory cells |
| 09/14/2006 | WO2006020684A3 Methods of regulating differentiation and treating of multiple myeloma |
| 09/14/2006 | WO2006008484A3 Detection of cellular stress |
| 09/14/2006 | WO2005117964A3 Cynomolgus prostate specific antigen |
| 09/14/2006 | WO2005086667A3 High efficiency peptide production in plant cells |
| 09/14/2006 | WO2005065418A3 Compositions and methods of use of targeting peptides for diagnosis and therapy |
| 09/14/2006 | WO2005007121A3 Mutant interleukin-2(il-2) polypeptides |
| 09/14/2006 | WO2005004928A3 Porous particulate collagen sponges |
| 09/14/2006 | WO2005001042A3 Smooth muscle progenitor cells |
| 09/14/2006 | WO2004108066A3 Neuronal regeneration and compound administration methods |
| 09/14/2006 | WO2004094655A3 Modulation of telomere-initiated cell signaling |
| 09/14/2006 | WO2004050831A3 Compositions, organisms and methodologies employing a novel human kinase |
| 09/14/2006 | WO2003089588A3 Novel molecules of the pyrin/nbs/lrr protein family and uses thereof |
| 09/14/2006 | WO2003072759A3 Cloning and characterization of slc26a6, slc26a1, and slc26a2 anion exchangers |
| 09/14/2006 | WO2003002721A3 Compositions and methods for inferring a response to a statin |
| 09/14/2006 | US20060206970 Alfalfa plants having improved standability and methods for producing same |
| 09/14/2006 | US20060206969 Alfalfa plants having improved fast recovery after harvest and methods for producing same |
| 09/14/2006 | US20060206968 Slow-maturing, determinate peas |
| 09/14/2006 | US20060206967 Genetic control of flowering |
| 09/14/2006 | US20060206964 Method for enhancing cellulose and modifying lignin biosynthesis in plants |
| 09/14/2006 | US20060206963 Nucleic acid constructs and methods for producing altered seed oil compositions |
| 09/14/2006 | US20060206962 Preparation of deallergenized proteins and permuteins |
| 09/14/2006 | US20060206960 Higher plant cytosolic er-based glycerol-3-phosphate acyltransferase genes |
| 09/14/2006 | US20060206958 Transforming a plant or plant cell with a nucleotide sequence operably linked to a promoter active in plant cells encoding an NRC1 protein and forming a transgenic plant; family Solanaceae, genus Solanum; cells, seeds, fruits |
| 09/14/2006 | US20060206957 Converting farnesyl-pyrophosphate to patchoulol, gamma -curcumene and other germacrane-type sesquiterpenes; vectors; host cells |
| 09/14/2006 | US20060206953 Derivation of embryonic stem cells |
| 09/14/2006 | US20060206952 Transgenic chickens |
| 09/14/2006 | US20060206950 In vivo imaging of e2f-fegulated bioluminescent proteins |
| 09/14/2006 | US20060206947 Heterodimeric protein binding compositions |
| 09/14/2006 | US20060205999 Transportation of biological matter to a target site in a closed volume for transplantation purposes |
| 09/14/2006 | US20060205667 Wt1 substitution pepides |
| 09/14/2006 | US20060205655 Nucleic acids encoding (poly) peptides having CHIPS activity |
| 09/14/2006 | US20060205640 Cationic peptide that inhibits the growth of both grampositive and/or gramnegative bacteria; isolated from the hemocytes of the sea squirt; can be used to treat antibiotic resistant tuberculosis, pneumonia, and urinary pathologies |
| 09/14/2006 | US20060205636 Oxytocin as cardiomyogenesis inducer and uses thereof |
| 09/14/2006 | US20060205598 Compositions for protecting plants from pathogens |
| 09/14/2006 | US20060205079 Amplifiable adeno-associated virus (AAV) packaging cassettes for the production of recombinant AAV vectors |
| 09/14/2006 | US20060205077 Targeted transgenesis using the rosa26 locus |
| 09/14/2006 | US20060205076 Osteochondral core centrifugation system and method of osteochondral repair |
| 09/14/2006 | US20060205075 In vitro differentiation and maturation of mouse embryonic stem cells into hepatocytes |
| 09/14/2006 | US20060205074 Neural progenitor cells derived from whole bone marrow |
| 09/14/2006 | US20060205073 Aspirating oocytes from transplanted ovarian tissue |
| 09/14/2006 | US20060205072 Enriched pancreatic stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
| 09/14/2006 | US20060205071 Methods for ex-vivo expanding stem/progenitor cells |
| 09/14/2006 | US20060205070 HIV TEV compositions and methods of use |
| 09/14/2006 | US20060205069 Compositions comprising a first agent which provides a primary activation signal to T cells and a second agent which stimulates an accessory molecule on the surface of T cells |
| 09/14/2006 | US20060205068 Useful in identifying and designing novel Bt toxin receptor ligands including novel insecticidal toxins; manipulating Bt toxin susceptibility in plant pests |
| 09/14/2006 | US20060205052 Bardet-Biedl susceptibility gene and uses thereof |
| 09/14/2006 | US20060205049 Method for the production of resveratrol in cell cultures |
| 09/14/2006 | US20060205038 antagonist antibody that blocks binding of IL-17; degenerative cartilaginous disorders and other inflammatory diseases |
| 09/14/2006 | US20060205033 Infectious clones of RNA viruses and vaccines and diagnostic assays derived thereof |
| 09/14/2006 | US20060205021 Mammalian IAP gene family, primers, probes and detection methods |
| 09/14/2006 | US20060205018 Polypeptides which have zinc metalloprotease activities and are referred to as IGS5, and polynucleotides encoding such polypeptides; use in therapy |
| 09/14/2006 | US20060205015 Method for detecting the interactions between a G protein-coupled receptor (GPCR) and one of the Galpha or Gbetagamma subunits |
| 09/14/2006 | US20060204982 Novel compositions and methods for cancer |
| 09/14/2006 | US20060204952 Technique for measuring cell-membrane properties in cultured cells grown on biomaterials in an Ussing chamber |
| 09/14/2006 | US20060204555 Thermosensitive polymers for therapeutic use and methods of preparation |
| 09/14/2006 | US20060204523 Flavivirus vaccine delivery system |
| 09/14/2006 | US20060204519 Genetic vaccine for generating immunity to human immunodeficiency virus-1 |
| 09/14/2006 | US20060204510 Bv8 nucleic acids and polypeptides with mitogenic activity |
| 09/14/2006 | US20060204508 Treatment of autoimmune diseases using an activator for the notch signalling pathway |
| 09/14/2006 | US20060204507 Method for generating an immune response and reagents therefor |
| 09/14/2006 | US20060204506 Anti-mesothelin antibodies |
| 09/14/2006 | US20060204498 Novel antagonists of cxcr3-binding cxc chemokines |
| 09/14/2006 | US20060204495 Isolation and identification of cross-reactive t cells |
| 09/14/2006 | US20060204494 Methionine sulfoxide antibodies |
| 09/14/2006 | US20060204493 Heteromultimeric molecules |
| 09/14/2006 | US20060204492 Compositions and methods for producing enhanced antibodies |
| 09/14/2006 | US20060204489 Protein C derivatives |
| 09/14/2006 | US20060204487 Production of high mannose proteins in plant culture |
| 09/14/2006 | US20060204483 determining whether a target cell expresses telomerase reverse transcriptase (TRT) by combining human T lymphocytes ex vivo with antigen-presenting cells containing a polypeptide that comprises at least 8 consecutive amino acids of telomerase reverse transcriptase |